Extending the findings from the UK cohort study, additional real-world data derived from the Taiwan National Health Insurance Databasewhich encompasses Asian populations characterized by lower gallstone prevalence, low-fat and high-fiber dietary patterns, and lower body mass indexalso documented an elevated risk of biliary-related diseases linked to GLP-1 RAs compared with SGLT-2 inhibitors [36]
They minimize systemic inflammation by many mechanisms: direct suppression of pro-inflammatory cytokine synthesis (TNF-, IL-6, IL-1), augmentation of anti-inflammatory mediators (IL-10, adiponectin), and alteration of immune cell morphologies
15 Dose adjustment does not appear to be necessary in patients with hepatic impairment, although exenatide has not been specifically studied in this population
Around 30-50% of users experience side effects during the first few weeks of therapy as appetite, digestion, and metabolism begin to change
What it means for GLP-1 companies: With brand-name GLP-1 prices falling, compounders face two choices: cut prices to maintain their competitive edge or drop copycat versions and partner with Novo and/or Lilly
Immunohistochemical detection of alpha and beta cells was performed using rabbit anti-insulin (3014, 1:800, Cell Signaling Technology) and mouse anti glucagon (G2654, 1:1,000, Merck) as primary antibodies and goat anti-rabbit AF750 (A21039, 1:100, Invitrogen) and donkey anti-mouse AF555 (A32773, 1:200, Invitrogen) as secondary antibodies
.webp)
